Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more
October 29, 2018 at 10:17 AM EDT
Small VistaGen is building a portfolio of drugs aimed at depression and other mental health conditions, while giant Gilead gets a lower effective tax rate — all that and more in our Health Care Digest.